Conditional degradation of SDE2 by the Arg/N-End rule pathway regulates stress response at replication forks.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
07 05 2019
Historique:
accepted: 24 01 2019
received: 03 01 2019
pubmed: 31 1 2019
medline: 26 11 2019
entrez: 31 1 2019
Statut: ppublish

Résumé

Multiple pathways counteract DNA replication stress to prevent genomic instability and tumorigenesis. The recently identified human SDE2 is a genome surveillance protein regulated by PCNA, a DNA clamp and processivity factor at replication forks. Here, we show that SDE2 cleavage after its ubiquitin-like domain generates Lys-SDE2Ct, the C-terminal SDE2 fragment bearing an N-terminal Lys residue. Lys-SDE2Ct constitutes a short-lived physiological substrate of the Arg/N-end rule proteolytic pathway, in which UBR1 and UBR2 ubiquitin ligases mediate the degradation. The Arg/N-end rule and VCP/p97UFD1-NPL4 segregase cooperate to promote phosphorylation-dependent, chromatin-associated Lys-SDE2Ct degradation upon UVC damage. Conversely, cells expressing the degradation-refractory K78V mutant, Val-SDE2Ct, fail to induce RPA phosphorylation and single-stranded DNA formation, leading to defects in PCNA-dependent DNA damage bypass and stalled fork recovery. Together, our study elucidates a previously unappreciated axis connecting the Arg/N-end rule and the p97-mediated proteolysis with the replication stress response, working together to preserve replication fork integrity.

Identifiants

pubmed: 30698750
pii: 5304317
doi: 10.1093/nar/gkz054
pmc: PMC6486553
doi:

Substances chimiques

Chromatin 0
DNA-Binding Proteins 0
PCNA protein, human 0
Proliferating Cell Nuclear Antigen 0
RPA1 protein, human 0
Replication Protein A 0
SDE2 protein, human 0
DNA 9007-49-2
UBR1 protein, human EC 2.3.2.27
UBR2 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
VCP protein, human EC 3.6.4.6
Valosin Containing Protein EC 3.6.4.6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3996-4010

Subventions

Organisme : NCI NIH HHS
ID : R01 CA218132
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nat Commun. 2014 Apr 28;5:3695
pubmed: 24770583
Mol Cell Biol. 2005 Aug;25(16):7120-36
pubmed: 16055722
J Cell Biol. 2016 Jan 4;212(1):63-75
pubmed: 26711499
Nat Rev Mol Cell Biol. 2008 Sep;9(9):679-90
pubmed: 18698327
Biochem Biophys Res Commun. 2011 Mar 18;406(3):444-8
pubmed: 21333630
Mol Cell. 2018 Jan 4;69(1):24-35.e5
pubmed: 29290612
Science. 2017 Nov 10;358(6364):797-802
pubmed: 29123070
Nat Cell Biol. 2016 Nov;18(11):1196-1207
pubmed: 27723717
PLoS Genet. 2016 Dec 1;12(12):e1006465
pubmed: 27906959
Nat Struct Mol Biol. 2010 Oct;17(10):1175-81
pubmed: 20835240
Mol Cell. 2015 Jan 8;57(1):150-64
pubmed: 25557546
Mol Cell Biol. 2003 Nov;23(22):8255-71
pubmed: 14585983
Genes Dev. 2013 Oct 15;27(20):2259-73
pubmed: 24142876
Nat Struct Mol Biol. 2016 Apr;23(4):270-7
pubmed: 26950370
Nat Struct Mol Biol. 2010 Oct;17(10):1182-7
pubmed: 20835242
Mol Cell. 2011 Oct 7;44(1):85-96
pubmed: 21981920
Science. 1986 Oct 10;234(4773):179-86
pubmed: 3018930
EMBO J. 2018 Jan 4;37(1):89-101
pubmed: 28947618
Science. 2007 May 25;316(5828):1160-6
pubmed: 17525332
Methods Enzymol. 2005;399:777-99
pubmed: 16338395
J Biol Chem. 2016 Oct 14;291(42):21956-21962
pubmed: 27601467
Science. 2014 Oct 24;346(6208):1253596
pubmed: 25342810
Mol Cell. 2016 Nov 17;64(4):704-719
pubmed: 27871366
Protein Sci. 2011 Aug;20(8):1298-345
pubmed: 21633985
Nat Cell Biol. 2016 Nov;18(11):1185-1195
pubmed: 27723720
Nat Struct Mol Biol. 2012 Nov;19(11):1093-100
pubmed: 23042607
DNA Repair (Amst). 2007 Jul 1;6(7):891-9
pubmed: 17363342
Front Genet. 2013 Apr 30;4:60
pubmed: 23641252
Nat Rev Mol Cell Biol. 2017 Oct;18(10):622-636
pubmed: 28811666
Nat Rev Cancer. 2015 May;15(5):276-89
pubmed: 25907220
Mol Cell. 2015 Sep 17;59(6):998-1010
pubmed: 26365379
J Biol Chem. 2009 Jan 16;284(3):1884-95
pubmed: 19008229
Nat Struct Mol Biol. 2012 Nov;19(11):1084-92
pubmed: 23042605
Nat Genet. 2016 Jan;48(1):36-43
pubmed: 26595769
Nat Rev Mol Cell Biol. 2011 Oct 21;12(11):735-47
pubmed: 22016057
Nature. 2007 Dec 20;450(7173):1258-62
pubmed: 18097415
Chromosoma. 2017 Feb;126(1):17-32
pubmed: 27086594
Science. 1991 Mar 15;251(4999):1351-5
pubmed: 1900642
Nat Cell Biol. 2006 Apr;8(4):339-47
pubmed: 16531995
Mol Cell. 2016 Nov 17;64(4):688-703
pubmed: 27871365
Mol Cell. 2012 Dec 28;48(6):926-33
pubmed: 23159736
Mol Cell. 2016 Oct 6;64(1):189-198
pubmed: 27716483
Mol Cell. 2018 Jan 18;69(2):182-194
pubmed: 29153394
Oncotarget. 2016 Jun 14;7(24):35724-35740
pubmed: 27232758
Cell. 1989 Mar 24;56(6):1019-32
pubmed: 2538246
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Mol Cell Biol. 2001 Dec;21(23):8007-21
pubmed: 11689692
Mol Cell. 2011 Oct 7;44(1):72-84
pubmed: 21981919
Cell Res. 2015 Jan;25(1):9-23
pubmed: 25403473
Mol Cell. 2017 Dec 7;68(5):830-833
pubmed: 29220651
Cell. 2007 May 18;129(4):665-79
pubmed: 17512402

Auteurs

Julie Rageul (J)

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA.

Jennifer J Park (JJ)

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA.

Ukhyun Jo (U)

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA.

Alexandra S Weinheimer (AS)

Biochemistry and Structural Biology graduate program, Stony Brook University, Stony Brook, NY 11794, USA.

Tri T M Vu (TTM)

Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.

Hyungjin Kim (H)

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA.
Stony Brook Cancer Center, Stony Brook School of Medicine, Stony Brook, NY 11794, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH